Video content above is prompted by the following question(s):
- What types of adverse effects may patients encounter with BTK inhibitor therapy? Venetoclax?
- How are these adverse effects typically managed and how does a multidisciplinary team contribute to this process?
- What guidance do you offer to patients to assist them in effective management of potential adverse events?
